The global Interleukin inhibitors market size will grow by USD 13.14 billion during 2019-2023. This market report provides a detailed analysis of the market by product (interleukin-23 inhibitors, interleukin-17 inhibitors, interleukin-6 inhibitors, and other interleukin inhibitors) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on many market vendors, including Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, and Regeneron Pharmaceuticals Inc.               

Key Insights on Interleukin Inhibitors Market - Global Forecast 2019-2023

Browse TOC and LoE with selected illustrations and example pages of interleukin inhibitors market

Request a FREE sample now!

Industry Overview

Unlike conventional therapies, interleukin inhibitors work directly in interleukin receptors, making them highly effective in treating autoimmune disease. There are several approved interleukin inhibitor molecules available in the market for treating autoimmune conditions such as psoriasis, rheumatoid arthritis, and Crohn’s disease. Further R&D is ongoing on interleukin inhibitor molecules, and clinical trials for late-stage molecules will positively influence market growth. Higher patient adherence to these drugs because of their higher affinity and specificity, compared with other conventional approved autoimmune therapeutics, will increase their sales.

Various campaigns are being conducted by organizations across the world to raise awareness about autoimmune conditions such as rheumatoid arthritis, asthma, psoriasis, and others and their available treatment. For instance, the Know Your Arthritis Foundation in India has started a campaign to raise awareness about arthritis-related problems through radio programs, television interviews, and free medical camps. Asthma is another widely prevailing condition that requires attention, and campaigns are being organized to raise awareness about the indication. The success of these campaigns is increasing the sales of therapeutics, such as interleukin inhibitors. The interleukin inhibitors market analysis predicts that as a result of these factors, the market will register a CAGR of over 13% during 2019-2023.

Top Companies in Interleukin Inhibitors Market

The global market is fragmented. To help clients improve their market positions, this interleukin inhibitors market forecast report provides an analysis of the market’s competitive landscape and offers information on the drugs offered by various companies. The report also includes information on the upcoming interleukin inhibitors market trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

The report offers a detailed analysis of several leading interleukin inhibitors manufacturers, including:

• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Novartis AG
• Regeneron Pharmaceuticals Inc.

Market Segmentation

Interleukin Inhibitors Market by Product

• Interleukin-23 inhibitors
• Interleukin-17 inhibitors
• Interleukin-6 inhibitors
• Other interleukin inhibitors

The interleukin-23 inhibitors market segment held the largest market share in 2018. It will account for the highest interleukin inhibitors market share over the forecast period. The high prevalence of psoriasis improved R&D on interleukin-23 inhibitors and the development of a robust pipeline will boost the growth of the market segment during the forthcoming years. This report provides an accurate prediction of the contribution of all the segments to the growth of the interleukin inhibitors market size.

Interleukin Inhibitors Market by Region

• Asia
• Europe
• North America
• ROW

With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the interleukin inhibitors market throughout the forecast period. The recent approvals of various drugs, availability of patient assistance programs, and high prevalence of various autoimmune conditions are some of the factors that will contribute to interleukin inhibitors market growth in this region.

Major Highlights of the Interleukin Inhibitors Market - Global Forecast 2019-2023

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the interleukin inhibitors market during the next five years
• Precise estimation of the global interleukin inhibitors market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the interleukin inhibitors industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of interleukin inhibitors companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch